Reported 8 months ago
On June 18, 2024, the newly listed stocks on the OTC market had contrasting performances. Medical Impact (6637) saw a rise in stock price due to strong financial performance, while Coincidence-KY (6617) dropped below the underwriting price on the first day due to delays in the schedule for its cancer drug. Medical Impact, with no losses in its 32-year history, is expected to achieve record profits this year. Coincidence-KY faced challenges with its cancer drug and is working on expanding the drug to treat tumors in animals, showing potential in global cancer treatment.
Source: YAHOO